Luteal phase-characteristic induction of I3SO3-GalCer in human cervical epithelia and uterine endometria, and follicular phase-characteristic formation of a ganglioside-derived negative charge gradient in different regions of fallopian tubes.
In a series of experiments on the hormone-dependent molecular alteration in the human genital tract during the menstrual cycle, we focused our attention on a change in the negative charge due to the sulfuric acid- and sialic acid-containing glycosphingolipids. Although a ganglioside-derived negative charge was maintained in the cervical epithelia and uterine endometria at a relatively constant concentration throughout the luteal and follicular phases, I3SO3GalCer in both tissues characteristically increased in the luteal phase, indicating that the synthesis of I3SO3-GalCer in both tissues is associated with the menstrual cycle. However, I3SO3-GalCer in mucosae of the fallopian tubes in both phases was present in a concentration similar to that in the uterine endometrium in the luteal phase, and the change in the concentration did not associated with the menstrual cycle. On the other hand, although the concentrations of I3SO3-GalCer and II3NeuAc-LacCer, a major ganglioside, were similar in different regions, that is, the isthmus, ampulla and fimbriae of the fallopian tubes in the luteal phase, II3NeuAc-LacCer was present in a gradually increasing concentration from the isthmus to the fimbriae in the follicular phase, giving a gradually decreasing ratio of I3SO3GalCer to ganglioside from the uterus to the fimbriae. These findings indicate that the metabolism of sulfo- and sialoglycosphingolipids in the human genital tract is strictly controlled by estrogen and progesterone.
Takamatsu
K
K
Department of Obstetrics and Gynecology, Keio University School of Medicine, Tokyo, Japan.
Kamei
K
K
Kubushiro
K
K
Kiguchi
K
K
Nozawa
S
S
Iwamori
M
M
D002584:Cervix Uteri / Q000378:metabolism*; D004717:Endometrium / Q000378:metabolism*; D005187:Fallopian Tubes / Q000378:metabolism; D005260:Female; D005498:Follicular Phase; D005699:Galactosylceramides / Q000096:biosynthesis* / Q000302:isolation & purification; D006028:Glycosphingolipids / Q000737:chemistry / Q000302:isolation & purification*; D006801:Humans; D008183:Luteal Phase; D009092:Mucous Membrane / Q000737:chemistry / Q000378:metabolism; D013433:Sulfoglycosphingolipids
D005699:Galactosylceramides; D006028:Glycosphingolipids; D013433:Sulfoglycosphingolipids; C084124:I(3)SO3-galactosylceramide